Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

0Q6H

Hofseth Biocare Asa (0Q6H)

Hofseth Biocare Asa
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0Q6H
DateTimeSourceHeadlineSymbolCompany
16/05/202416:00UK RegulatoryHofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
10/05/202422:30UK RegulatoryHofseth Biocare ASA: Annual General Meeting completedLSE:0Q6HHofseth Biocare Asa
19/04/202421:00UK RegulatoryHofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024LSE:0Q6HHofseth Biocare Asa
19/04/202416:00UK RegulatoryHofseth Biocare ASA: HBC ANNUAL REPORT 2023LSE:0Q6HHofseth Biocare Asa
06/04/202403:08UK RegulatoryHofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDINGLSE:0Q6HHofseth Biocare Asa
21/03/202420:40UK RegulatoryHofseth Biocare ASA: UPDATED COMPANY PRESENTATIONLSE:0Q6HHofseth Biocare Asa
14/03/202422:12UK RegulatoryHofseth Biocare ASA: CHAIR KRISTIN FJELLBY GRUNG STEPS DOWNLSE:0Q6HHofseth Biocare Asa
09/02/202418:00UK RegulatoryHofseth Biocare ASA: FOURTH QUARTER 2023 AND FULL YEAR FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
07/02/202401:56UK RegulatoryHofseth Biocare ASA: HBC Immunology Inc successfully completes first animal model of prostate cancer with FT-005 in combination with hormonal (anti-androgen) therapy demonstrating significant anti-tumour activityLSE:0Q6HHofseth Biocare Asa
 Showing the most relevant articles for your search:LSE:0Q6H